SymBiosis II

Venture Capital

Bentonville, Arkansas biotherapeutics venture capital firm investing in bioengineering and serious disease treatments.

Bentonville, United States · 8+ investments · 7 portfolio companies

Seed
Early Stage
Growth
Biotech
Biotherapeutics
Life Sciences
Headquarters
Bentonville, United States
Founded
2021
AUM
$357.0M
Portfolio Companies
7
Total Investments
8
Last Investment
Jan 2026
Geographic Focus
United States

Investment Thesis

Early-stage biotherapeutics investing focused on advancing innovations for serious and life-threatening diseases through conviction-led funding.

SymBiosis II is a Venture Capital firm based in Bentonville, United States. It has made 8 investments, including GreenLight Bio, Carisma Therapeutics and Corxel. Focus areas include Biotech and Biotherapeutics.

Portfolio7

Co-investors24

Sign up to view co-investors

24 co-investors across 25 shared portfolio companies — who they back alongside, and how often they lead.

Venture Capital ×16 · Hedge Fund ×4 · Corporate VC ×2 · 25 shared rounds

Investment History

Sign up to view investment history

Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.

Your firm? Embed this profile

Add the live badge to your site — it stays current as your portfolio data updates.

SymBiosis II on Indexed.vc
<a href="https://indexed.vc/investors/symbiosis-ii"><img src="https://indexed.vc/api/badge/investor/symbiosis-ii" alt="SymBiosis II on Indexed.vc" width="260" height="76" /></a>